Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

8.98EUR
18 Sep 2018
Change (% chg)

€0.10 (+1.18%)
Prev Close
€8.87
Open
€8.80
Day's High
€9.13
Day's Low
€8.80
Volume
27,444
Avg. Vol
43,084
52-wk High
€29.70
52-wk Low
€8.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.27 -1.668
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
FY 2016 Dec '16 1.74 -1.433
Jun '16 2.40 -1.310
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 5 5.02 11.00 0.00 4.15
Year Ending Dec-19 4 7.43 13.00 2.00 27.37
Earnings (per share)
Year Ending Dec-18 4 -2.71 -2.25 -3.19 -2.41
Year Ending Dec-19 4 -3.17 -2.35 -3.54 -1.91
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.71 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 0.86 0.93 0.89
Price to Sales (TTM) 80.61 114.98 5.75
Price to Book (MRQ) -- 15.51 5.00
Price to Tangible Book (MRQ) -- 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 411.55 8.01
Sales (TTM) vs TTM 1 Yr. Ago -8.67 80.36 5.64
Sales - 5 Yr. Growth Rate 35.25 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 29.15 20.61
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 81.34 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) -- 5.46 3.03
LT Debt to Equity (MRQ) -- 35.26 12.51
Total Debt to Equity (MRQ) -- 37.08 16.85
Interest Coverage (TTM) -- -102.35 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -600.64 10.68
Operating Margin (TTM) -736.87 -759.75 4.32
Operating Margin - 5 Yr. Avg. -331.17 -621.68 6.11
Pre-Tax Margin (TTM) -727.19 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -337.58 -627.38 6.51
Net Profit Margin (TTM) -727.87 -734.97 1.48
Net Profit Margin - 5 Yr. Avg. -337.31 -630.42 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 23,230,020 860,375,045
Net Income/Employee (TTM) -301,682 3,144,156 101,207,177
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.16 11.13
Return on Assets - 5 Yr. Avg. -38.25 3.51 12.40
Return on Investment (TTM) -- 1.78 14.61
Return on Investment - 5 Yr. Avg. -46.07 2.56 16.13
Return on Equity (TTM) -- 3.29 16.33
Return on Equity - 5 Yr. Avg. -51.29 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 37 53
13 Week -7.07 -10.79 75 66
26 Week -12.20 -15.88 78 80
52 Week 35.52 13.27 99 50
YTD 76.06 59.71 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.00%
# of Holders: 24
Total Shares Held: 9,685,142
3 Mo. Net Change: -1,324,185
# New Positions: 1
# Closed Positions: 6
# Increased Positions: 5
# Reduced Positions: 9
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.